| Robert C Parke, MD | |
|
Boston Meps Medical Section, 495 Summer Street, Boston, MA 02210 | |
| (617) 753-3112 | |
| Not Available |
| Full Name | Robert C Parke |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | Boston Meps Medical Section, Boston, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063446714 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 219691 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Robert C Parke, MD Po Box 874, Barnstable, MA 02630-0874 Ph: (617) 753-3112 | Robert C Parke, MD Boston Meps Medical Section, 495 Summer Street, Boston, MA 02210 Ph: (617) 753-3112 |
News Archive
A team led by a University of Maryland School of Medicine (UM SOM) researcher, working as a grantee from the National Institutes of Health (NIH), has identified a number of existing drugs that could be "repurposed" to fight outbreaks of Middle East respiratory syndrome coronavirus (MERS-CoV) and severe acute respiratory syndrome coronavirus (SARS-CoV).
During the G20 summit opening Thursday in Pittsburgh, President Obama will propose countries around the world phase out government subsidies that promote the production and use of fossil fuels "that spew carbon dioxide, the chief greenhouse gas," the Associated Press reports (Borenstein, 9/23).
Genentech and XOMA have announced preliminary 30-month (120 weeks) results from an open-label study evaluating the safety and efficacy of long-term continuous treatment with RAPTIVA® (efalizumab) in adults with moderate-to-severe chronic plaque psoriasis.
Case Western Reserve University (CWRU) School of Medicine (SOM) has received a Robert Wood Johnson grant to fund a Public Health Practice Based Research Network called The Ohio Research Association for Public Health Improvement (RAPHI).
Soligenix, Inc., a late-stage biotechnology company, announced today the publication of an article in the February 2010 edition of Vaccine, which describes preclinical formulations of RiVax™, its ricin toxin vaccine, with heightened stability. The article was authored by the Company's collaborators at the University of Texas Southwestern Medical Center at Dallas (UT Southwestern) where the vaccine originated. RiVax™ is currently being evaluated in Phase 1 human safety and immunogenicity trials, as well as non-human primate trials for efficacy.
› Verified 4 days ago
Lidya H Wlasiuk, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 850 Harrison Ave, Yacc 5, Boston, MA 02118 Phone: 617-414-2080 Fax: 617-414-2090 | |
Brian R Penti, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 850 Harrison Ave, Yacc 4, Boston, MA 02118 Phone: 617-414-2080 Fax: 617-414-2090 | |
Alysia L Green, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 915 Commonwealth Ave Rear, Boston, MA 02215 Phone: 617-358-3400 Fax: 617-358-3710 | |
Shahnaz Rahman, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 Harrison Ave, Boston, MA 02118 Phone: 404-259-4008 | |
Dr. Amy Min He, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 637 Washington St, Boston, MA 02124 Phone: 617-825-9660 | |
Katherine A Gergen Barnett, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11 Melnea Cass Blvd, Boston, MA 02119 Phone: 617-414-2080 Fax: 617-414-2090 | |
Dr. Xiangxin Chen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 145 South St, Boston, MA 02111 Phone: 617-482-7555 Fax: 617-482-2930 |